Teva Suspends Sales for Zecuity

Drug Industry Daily
A A
Teva Pharmaceutical is voluntarily scratching all sales, marketing and distribution for its migraine patch Zecuity, following a stream of reports linking the patch to burns and permanent scarring.

To View This Article:

Login

Subscribe To Drug Industry Daily